Acorda Therapeutics Inc (NASDAQ:ACOR)

29.90
Delayed Data
As of 4:00pm ET
 -0.60 / -1.97%
Today’s Change
16.55
Today|||52-Week Range
36.35
+39.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line17.7M11.1M-35.6M-223.4M
 
 
 
 
 
Depreciation8.5M15.0M21.6M23.2M
 
 
 
 
 
Total Other Cash Flow46.4M33.9M45.3M377.8M
 
 
 
 
 
Funds From Operations79.2M64.0M20.1M123.7M
 
 
 
 
 
Funds From/For Other Operating Expenses4.2M20.3M-9.5M26.9M
 
 
 
 
 
Net Cash Flow - Operating Activities74.9M43.7M29.6M96.8M
 
 
 
 
 
 
InvestingIncrease In Investments-580.4M-434.7M-40.2M0.00
 
 
 
 
Decrease In Investments770.5M356.5M240.0M0.00
 
 
 
 
Capital Expenditures-5.1M-5.9M-6.2M-13.7M
 
 
 
 
 
Fixed Asset Disposal------6.4M
 
 
Net Assets From Acquisitions -476.2M0.00-294.4M0.00
 
 
 
Net Cash Flow Investing-293.8M-85.2M-101.7M-8.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-374.0K----
 
 
Long Term Borrowings337.5M0.00-1.6M0.00
 
 
 
Long Term Debt Reduction-562.0K-501.0K---2.4M
 
 
 
 
Net Proceeds Stock Sale16.0M18.1M75.5M10.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.00-60.0K
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.00194.0K--50.8M
 
 
 
Other Uses - Financing0.00--56.0K0.00
 
 
Net Cash Flow - Financing352.9M17.4M73.9M58.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.0K---2.2M1.2M
 
 
 
 
 
Net Change In Cash134.1M-24.1M1.8M147.6M